Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: A comparative immunohistochemical study

Journal of Pathology

Volumn 180, Issue 3, 1996, Pages 259-265

  Mueller, James ^a   Mueller, Elke ^a   Hoepner, Ingrid ^a   Jütting, Jutta ^b   Bethke, Birgit ^c   Stolte, Manfred ^c   Höfler, Heinz ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

bcl 2; Carcinogenesis; Colon; de novo carcinoma; Immunohistochemistry; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; COLON ADENOMA; COLON CARCINOMA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECTAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029835823     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199611)180:3<259::AID-PATH654>3.0.CO;2-1     Document Type: Article

References (27)

1. Morson B. The polyp-cancer sequence in the large bowel. Proc R Soc Med 1974; 67: 451-457.
2. Lotfi AM, Spencer RJ, Ilstrup DM, Melton LJ III. Colorcctal polyps and the risk of subsequent carcinoma. Mayo Clin Proc 1986; 61: 337-343.
3. Fearon ER, Jones PA. Progressing toward a molecular description of colorectal cancer development. FASEB J 1992; 6: 2783-2790.
4. Vogelstein B. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
5. O'Brien M, Winawer SJ, Zauber AG. The national polyp study: patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-379.
6. Winawer S, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 392: 1977-1981.
7. Kuramoto S, Oohara T. Flat early cancers of the large intestine. Cancer 1989; 4: 950-955.
8. Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E. Early colorectal carcinoma with special reference to its development de novo. Cancer 1989; 64: 1138-1146.
9. Bedenne L, Faivre J, Boutron MC, Piard F, Cauvin JM, Hillon P. Adenoma carcinoma sequence or 'de novo' carcinogencsis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer 1992; 69: 883-888.
10. Stolte M, Bethke B. Colorectal mini-de novo carcinoma: a reality in Germany too. Endocopy 1995; 27: 286-290.
11. Bertorelle R, Esposito G, Del Mislro A, et al. Association of p53 gene and protein alterations with metastases in colorectal carcinoma. Am J Surg Pathol 1995; 19: 463-471.
12. Goh H, Chan CS, Khine K, Smith DR. p53 and behaviour of colorectal cancer. Lancet 1994; 344: 233-234.
13. Korsmeyer S. bcl-2 initiates a new category of oncogenes: regulators of cell death (Review). Blood 1992; 80: 879-886.
14. Bosari S, Moneghini L, Graziani D, et al. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas and adenocarcinomas. Hum Pathol 1995; 26: 534-540.
15. Pascal R. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Hum Pathol 1994; 25: 1160-1171.
16. UICC. TNM Atlas: An Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. 3rd edn. Heidelberg: Springer-Verlag, 1993.
17. Bronner MP, Culin C, Reed JC, Furth EE. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 1995; 146: 20-26.
18. Bosari S, Viale G, Bossi P, et al. Cytoplasmic accumulation of p53: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994; 86: 681-687.
19. Bethke B, Walter T, Stolte M. Endoskopische Polypektomie: Vergleich der Häufigkeit kolorektaler Ex-Adenoma- und De-novo -Frühkarzinome. Coloproctology 1995; 17: 176-183.
20. Yamamura-Idei Y, Satonaka K, Fujimori T, Maeda S, Chiba T. p53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis. Dig Dis Sci 1994; 39: 2043-2048.
21. Muto T, Kamiya J, et al. Small 'flat adenoma' of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum 1985; 28: 847-851.
22. Hermanek P. Dysplasia-Karzinom-Sequenz im Kolorektum. Zentralbl Chir 1992; 117: 476-482.
23. Aoki T, Takeda S, et al. APC and p53 mutations in de nova colorectal adenocarcinomas. Hum Mutation 1994; 3: 342-346.
24. Blank M, Klussman E, et al. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 1992; 59: 301-306.
25. Yao T, Tada S, Tsuneyoshi M. Colorectal counterpart of the gastricdepressed adenoma. Am J Surg Pathol 1994; 18: 559-568.
26. Purdie C, O'Grady J, Piris J, Wyllie AH, Bird CC. p53 expression in colorectal tumors. Am J Pathol 1991; 138: 807-813.
27. Mateo M, Sanchez-Beato M, Martinez JC, Orfao A, Orradrc JL, Piris MA, p53, Rb, and bcl-2 expression during the cell cycle; a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J Clin Pathol 1995; 48: 151-159.